Trial Profile
IMaging pilot study of the avß6 integrin radiotracer [18F]A20FMDV2 in PAtients with solid Cancer Types
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs GSK 2634673F (Primary)
- Indications Breast cancer; Head and neck cancer; Pancreatic cancer; Solid tumours
- Focus Diagnostic use
- 11 Dec 2015 New trial record